Skip to main content
Vance Fowler, MD, Infectious Disease, Durham, NC

Vance Fowler MD MHS


Professor, Medicine, Duke University School of Medicine

Join to view full profile
  • 2100 Erwin RdDurham, NC 27705

  • Phone+1 919-620-4467

Dr. Fowler is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Infectious Disease, 1996 - 1999
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1993 - 1996
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1993

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1995 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcu...  
    Helen W Boucher, G Ralph Corey, Vance G Fowler, Clinical Infectious Diseases

Other

Press Mentions

  • Where Are We in the Battle Against Antibiotic-Resistant Infections?
    Where Are We in the Battle Against Antibiotic-Resistant Infections?December 4th, 2025
  • The Free Market Is Failing Us on Antibiotics
    The Free Market Is Failing Us on AntibioticsDecember 25th, 2022
  • DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on Battlefield
    DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on BattlefieldSeptember 30th, 2021

Grant Support

  • HLA Fine Mapping to Elucidate S. aureus SusceptibilityDUKE UNIVERSITY2021–2026
  • Antibacterial Resistance Leadership Group (ARLG)DUKE UNIVERSITY2013–2026
  • Antibacterial Resistance Leadership Group (ARLG)DUKE UNIVERSITY2013–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: